Pittsburgh Woman Finds Wearable Therapy® a "God-send" After Living with Chronic Pain for 8 Years

ANN ARBOR, Mich., Dec. 1, 2015 /PRNewswire/ -- Axiobionics (Axio), a leading medical device company focused on the rehabilitation of patients with physical disabilities, creates individually made suits that stimulate nerves and muscles to treat muscle atrophy, spasms, and chronic pain. The suits were designed to help patients overcome persistent and disabling pain; the kind of pain that decreases quality of life, reduces sleep, and prevents people from having the ability to work. 

Sara Berg has been living with high levels of back and leg pain and severe muscle spasms for 8 years after a work-related accident. What's worse for Sara is pain medications cause constant nausea so she is unable to take them, while other pain treatments she has tried failed to alleviate the pain. She lost all hope for a chance to live a quality life. 

The breakthrough came when Sara's orthopedic surgeon referred her to Axiobionics. In just two visits, she was fit with the Wearable Therapy^® product for the lower back and left leg.

Sara wears Axio's tailored BioBrief and BioSleeve throughout the day eliminating the pain and spasms. Even when she takes it off, her pain stays away for 8-12 hours so she can sleep well throughout the night. 

"Such simple pleasures as being able to walk or sleep are so easily taken for granted by most," says Sara, "and I couldn't be happier to say that I can now do both without pain, thanks to Wearable Therapy. I can start living life again."

With a passion for excellence in patient care, Axiobionics designs, manufactures, and fits a wide array of innovative and life-changing medical devices for people with medical conditions effecting the musculoskeletal and nervous systems. Axiobionics promotes healthier bodies by providing conservative, non-pharmacological, patient-matched solutions to complex medical conditions. 

Media contact:
Gloria Hess
256-603-4165

Photo - http://photos.prnewswire.com/prnh/20151201/292120 
Photo - http://photos.prnewswire.com/prnh/20151201/292121

SOURCE Axiobionics